mitralign

Mitralign Inc. is a venture capital-backed private company located in the suburbs of Boston, Massachusetts. The company is developing an innovative catheter-based technology for the percutaneous treatment of functional mitral regurgitation. The novel Mitralign system mimics surgical annuloplasty by delivering a series of surgical implants directly into the mitral valve annulus via a catheter. Tightening these implants together reduces the size of the mitral valve annulus and valve opening.Mitralign is funded by top-tier venture capitalists and has two major cardiovascular device companies as investors.